This week, we talked with European Commission Trade Commissioner Cecilia Malmstrom about negotiating a trade deal between the EU and U.S. Dennis Purcell of Aisling Capital came on to discuss why the biotech sector was worried about the FDA Commissioner Scott Gottlieb's resignation. Jamie Montgomery of March Capital Partners joined from his namesake conference to talk about how the ongoing techlash was weighing on attendees. Then James Anderson,  partner and portfolio manager at Ballie Gifford, came to to discuss assessing his investment performance without benchmarks.

See omnystudio.com/listener for privacy information.